1-3 of 3
Rachel Brown
Close
Sort by
Journal Articles

High Responses Rates with Single Agent Belantamab Mafodotin in Relapsed Systemic AL Amyloidosis

Jahanzaib Khwaja, Joshua Bomsztyk, Ceri Bygrave, Adam Forbes, Senthilkumar Durairaj, Savio Fernandes, James Taylor, Pamela Paterson, Gillian Brearton, Charles Crawley, Oonagh Sheehy, Rachel Brown, Richard Soutar, Mamta Garg, Andrzej Rydzewski, Krzysztof Jamroziak, Emma Dowling, Nuno Correia, Sarah Worthington, Shameem Mahmood, Ashutosh D. Wechalekar
Journal: Blood
Blood (2023) 142 (Supplement 1): 3408.
https://doi.org/10.1182/blood-2023-182042
Published: 2023
Journal Articles

Evaluating the PET Parameters SUVmax and TMTV in the Setting of Autologous Stem Cell Transplantation for DLBCL

Rachel Brown, MD, Alessandro Lambertini, MD, Michael S Hofman, MBBS (Hons), FRACP, FAANMS, Mathias Bressel, M.Sc, Michael P Macmanus, MD MRCP, MBBS, Andrew Wirth, MBBS, MD FRACP, FRANZCR, John F. Seymour, Michael Dickinson, DMed Sci, Belinda Campbell, MBBS, MMed, FRANZCR
Journal: Blood
Blood (2020) 136 (Supplement 1): 38.
https://doi.org/10.1182/blood-2020-135920
Published: 2020
Journal Articles

Advanced Age at Transplant Increases the Risk of Second Solid Malignancy (SSM) after Haematopoetic Stem Cell Transplantation (HSCT)

John Murray, RGN, MSc, John Chadwick, MRCP, Adrian Bloor, PhD FRCPath, Jim Cavet, FRCPath, Mike Dennis, FRCPath, Tim Somervaille, FRCPath, Sven Armin Sommerfeld, MRCP, John Eliott, MRCP, Siobhan Muthia, MRCP, Angie Leather, RGN BSc, Rita Angelica, RGN BSc, Rachel Brown, MRCP, Jo Tomlins, MSc, Samar Kulkarni, FRCPath
Journal: Blood
Blood (2014) 124 (21): 3952.
https://doi.org/10.1182/blood.V124.21.3952.3952
Published: 2014